Table 2 Case characteristics
From: Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
Case | Gender | Age | BMI | Vaccine type | Dose | Time from vaccination to death (days) | Time from death to autopsy (days) | Comorbidity | Grading – myocarditis (0 – 3) | Grading – epicarditis (0 – 3) | PCR analysis | Assessment of causal relationsship |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | male | 46 | 31.8 | Cormirnaty (BioNTech) | First | 0 | 7 | AH | 2 | 0 | Negative | Likely |
2 | female | 50 | 20 | Spikevax (Moderna) | First | 1 | 3 | - | 1 | 2 | Negativ | Likely |
3 | female | 62 | 22.5 | Cormirnaty (BioNTech) | First | 7 | 3 | COPD | 1 | 1 | Negative | Possible |
4 | male | 55 | 30.1 | Cormirnaty (BioNTech) | Second | 4 | 3 | - | 2 | 3 | Negative | Likely |
5 | female | 75 | 27,9 | Cormirnaty (BioNTech) | First | 1 | 9 | AH, DM, Hashimoto´s thyroiditis | 2 | 2 | HHV6 | Possible |